We’re often reminded of why we put an effort in supporting people facing cancer – whether it comes through a patient story or through an organization’s investment in our work. This week, we humbly received another reminder: on Friday, May 22, the International Chronic Myeloid Leukemia (CML) Foundation awarded our CEO Pat Garcia-Gonzalez with the inaugural ERSAP (Emerging Region Support and Partnership) Prize. The iCMLf Directors and Scientific Advisors selected Pat because of her continued commitment, and The Max Foundation’s aim, to help people face cancer with dignity and hope.

Tim Hughes, iCMLf Chair, stated, “Pat strongly believes that people living with CML have the right to access the best possible treatment and support, wherever they live. This is why she has been so determined to make new drugs for CML fully available to patients in emerging economic regions through access programs, education and global advocacy efforts.”

“I am honored to receive the first ever ERSAP Prize and thank our partners at the International CML Foundation for their recognition.” Pat stated. “I take this award as an opportunity to reflect on how providing access to life-saving treatments to people around the world makes our global community stronger and a more just place to live. There are still so many people around the world who deserve advocacy and support and we carry out our work on their behalf. This award reignites our passion for finding innovative solutions to help people face cancer with dignity and hope.”

You can read further details about why Pat was selected for the ERSAP Prize on the iCMLf announcement.blogpost384_1